FDA Takes Action Following Ovarian Cancer Lawsuits

April 06, 2017 – – Huge payouts have been awarded to plaintiffs who have filed lawsuits against Johnson & Johnson (J&J) in relation to its talcum powder products. As a result of these ovarian cancer lawsuits, the FDA has now started to research the link between these products and the form of cancer. This is a multipronged study in which the FDA will conduct its own internal research, while collecting external data as well.

The Office of Women’s Health of the FDA has released a statement late last year, providing grants to those who are studying the causal relationship between talc powder and ovarian cancer. Furthermore, the Office of Color and Cosmetics of the FDA is also looking at updating its review of epidemiological studies, which will also look at the link between talcum powder and ovarian cancer. Sources report that the FDA has also made funds available for a piece of internal research, and this study is believed to take several years to complete.

Talc is used in many hygiene products and cosmetics, including baby powder, and people all over the country have used it, believing it to be safe. However, there are now many lawsuits pending in which it is alleged that it actually leads to ovarian cancer. The claim is that talc, when found naturally, contains asbestos, which has been clinically proven to be a carcinogen. In the 1970s, it was uncovered that talc contained asbestos, after which it was ruled that it should be made asbestos-free. However, according to plaintiffs, this asbestos-free talc can still cause ovarian cancer when applied to the genital area.

Although further research still needs to be completed, researchers from Germany and this country have completed a study that was published in the European Journal of Cancer Prevention. They looked at 30 different clinical trials, including some 300,000 participants, and found that the risk of developing ovarian cancer was 22% higher in women who used talcum powder on their genital area. Additionally, they were at a 24% increased risk of developing serious carcinoma.

So far, four ovarian cancer lawsuits have been heard, three of which were trialed in favor of the plaintiffs, resulting in multi-million dollar payouts.

###

Contact Drug-Lawsuits.org:

info@drug-lawsuits.org

ReleaseID: 60016231